Key result
Macrophage-specific IKKα knockout exacerbated DOX-induced myocardial injury, ventricular remodeling, and inflammation, highlighting the protective role of the IKKα-STAT3-S727 pathway.
Why the study?
Macrophages play a role in doxorubicin-induced cardiomyopathy, but the underlying mechanisms remain unclear.
Does macrophage IKKα deficiency exacerbate doxorubicin-induced cardiomyopathy in a mouse model?
Does macrophage IKKα deficiency exacerbate doxorubicin-induced cardiomyopathy in a mouse model?
Macrophage IKKα protects against doxorubicin-induced cardiomyopathy by regulating the STAT3-S727 axis, highlighting a novel therapeutic target for anthracycline cardiotoxicity.
Macrophage IKKα may promote doxorubicin cardiomyopathy in mice; leaves open whether inhibition could reduce cardiotoxicity in patients.
Doxorubicin (DOX) is an effective chemotherapeutic drug, but its use can lead to cardiomyopathy, which is the leading cause of mortality among cancer patients. Macrophages play a role in DOX-induced cardiomyopathy (DCM), but the mechanisms undlerlying this relationship remain unclear. This study aimed to investigate how IKKα regulates macrophage activation and contributes to DCM in a mouse model. Specifically, the role of macrophage IKKα was evaluated in macrophage-specific IKKα knockout mice that received DOX injections. The findings revealed increased expression of IKKα in heart tissues after DOX administration. In mice lacking macrophage IKKα, myocardial injury, ventricular remodeling, inflammation, and proinflammatory macrophage activation worsened in response to DOX administration. Bone marrow transplant studies confirmed that IKKα deficiency exacerbated cardiac dysfunction. Macrophage IKKα knockout also led to mitochondrial damage and metabolic dysfunction in macrophages, thereby resulting in increased cardiomyocyte injury and oxidative stress. Single-cell sequencing analysis revealed that IKKα directly binds to STAT3, leading to the activation of STAT3 phosphorylation at S727. Interestingly, the inhibition of STAT3-S727 phosphorylation suppressed both DCM and cardiomyocyte injury. In conclusion, the IKKα-STAT3-S727 signaling pathway was found to play a crucial role in DOX-induced cardiomyopathy. Targeting this pathway could be a promising therapeutic strategy for treating DOX-related heart failure.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied DOX-induced cardiomyopathy. Macrophage-specific IKKα knockout vs. Control mice was evaluated on Myocardial injury, ventricular remodeling, inflammation, and proinflammatory macrophage activation. Macrophage-specific IKKα knockout exacerbated DOX-induced myocardial injury, ventricular remodeling, and inflammation, highlighting the protective role of the IKKα-STAT3-S727 pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: